Tag: Delgocitinib
Delgocitinib Sustains Quality of Life Gains Through 52 Weeks in Chronic Hand Eczema – Dermatology Times
eczemarelief
April 13, 2026
Delgocitinib Reduces Work and Activity Burden in CHE – Dermatology Times
eczemarelief
March 6, 2026
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – BioSpace
eczemarelief
September 19, 2025
New Hand Eczema Treatment Anzupgo (Delgocitinib) Gets FDA Okay – Everyday Health
eczemarelief
August 2, 2025